Pinz Capital Management’s CureVac CVAC Stock Holding History

Pinz Capital Management’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-40,200	Closed	-$547K	–	117
2022 Q2	$547K	Buy	+40,200	New	+$665K	0.37%	89
2020 Q4	–	Sell	-3,600	Closed	-$168K	–	142
2020 Q3	$168K	Buy	+3,600	New	+$201K	0.06%	104

Other funds holding CVAC

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Pinz Capital Management's CVAC Position: Q3 2022 in Review

Pinz Capital Management sold out of CureVac (CVAC) in Q3 2022, closing a stake of 40,200 shares — an estimated $547K sold.

Pinz Capital Management first reported a position in CVAC in Q3 2020 and held it in 2 quarters. The position peaked at $547K in Q2 2022. 83 funds tracked by Wall St. Rank hold CVAC as of Q3 2022.

Pinz Capital Management reported no remaining CureVac position as of Q3 2022 after selling out during the quarter.
Pinz Capital Management sold 40,200 CureVac shares in Q3 2022, an estimated $547K.
Pinz Capital Management first reported a position in CureVac in Q3 2020 and held it in 2 quarters.
Pinz Capital Management's CureVac position peaked at $547K in Q2 2022.
83 funds tracked by Wall St. Rank held CureVac as of Q3 2022.

Based on Pinz Capital Management's 13F filing for Q3 2022, filed 15 Nov 2022.